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Introduction
This article is meant to disseminate recent scientific progress on 
Gilles de la Tourette Syndrome (TS).
Methods
We searched PubMed from time to time during 2019 using the 
search strategy “(”Tic Disorders“[MeSH] OR Tourette NOT 
Tourette[AU]) AND 2019[PDAT] NOT 1950:2018[PDAT]”. 
Colleagues also recommended articles, and we attended selected 
medical conferences. We selected material for this review 
subjectively, guided by our judgment of possible future impact 
on the field.
Results
Phenomenology and natural history
Müller-Vahl et al.1 present a stimulating argument based on 
data that demonstrate a severity continuum between chronic 
tics and TS using a database regrouping 1018 subjects. They 
thus conclude that TS and chronic tics do not represent distinct 
diagnostic categories. Accordingly, they suggest the introduc-
tion of the the term “tic spectrum disorders” (in analogy to 
autism spectrum disorders, ASDs) which might present the added 
benefit of decreased social stigma related to TS.
Martino and Hedderly provide an excellent review on the 
differences between tics and stereotypies, and their clinical 
management2
A useful resource is the video atlas of various vocalizations 
that includes tics and helps with differential diagnosis3.
Epidemiology. Several good epidemiological studies and 
meta-analyses on the childhood prevalence of TS have been 
published over the past years, with most figures ranging 
between 0.5 to 0.8%, but they could be much higher. However, 
prevalence in adulthood remains unknown. Levine et al. 
analysed three studies (published 1986, 2011 and 2016) involving 
2,356,485 participants4. Overall prevalence of TS in adulthood 
was estimated to be 118 cases of TS per million adults, that 
is 0.0118%. This appears very low, even factoring in remission 
in two thirds to three quarters of childhood cases during 
adulthood (which, in itself, is debatable). Clearly, more research 
is needed on this important topic, preferably using current 
DSM-5 criteria.
Tic suppression. Forty-five children with tics starting on 
average only 3–4 months ago were assessed with clinical and 
psychological methods and reassessed at the 12-month 
anniversary of their first tic5. Children who were less able at 
the first visit to suppress tics while given immediate rewards for 
10-second tic-free intervals had worse clinical status (higher 
YGTSS total tic score) at the follow-up visit six to nine 
months later. This finding adds to the meager prognostic clues 
available for Provisional Tic Disorder a simple, clinically 
relevant test.
Sensory phenomena and premonitory urges. Rae and colleagues 
provide a very thoroughly discussed computational model of 
how tics and premonitory sensations may be generated6. The 
model links premonitory phenomena and tics to a hypothesized 
overly precise internal estimate of sensory information and 
predicted movement, and has the key advantage of generating 
some testable hypotheses.
Other. David Mataix-Cols’ group continue their epidemio-
logical exploration of patients with TS and chronic tic dis-
orders (CTD) using the Swedish National Patient Register. 
This time, they looked for metabolic and cardiovascular 
disorders in these patients and find that the risk is doubled 
compared to the general population, especially with regard 
to obesity, type 2 diabetes and circulatory system diseases. 
With regard to co-morbidities, the presence of attention-deficit/ 
hyperactivity disorder (ADHD) significantly increased the 
risk (however, excluding ADHD does not normalize the risk, 
still 50% higher than in the general population). Most sur-
prisingly, use of antipsychotic medication for more than 
one year was associated with a significantly decreased risk 
for metabolic and cardiovascular disorders in patients with 
TS or CTD. This counterintuitive finding, given antipsychotics’ 
propensity to induce metabolic syndrome, requires further 
clarification. For now, the authors speculate that patients with 
TS or CTD receiving medication benefit from frequent follow 
ups and better monitoring of their general health. In any case, 
this is a further demonstration, after papers on suicide and 
educational attainment in patients with TS or CTD, that 
chronic tic disorders are far from benign and require correct 
diagnosis, then regular care and follow up7.
Etiology
Genetics. 2019 has seen the publication of a variety of studies 
using whole exome sequencing. Depienne et al.8 investigated 
120 TS patients and identified disrupting variants of OPRK1, 
encoding the opioid kappa receptor, in a significant subset of 
subjects compared to controls. This result points to a role, 
discussed since the 1980s, of the opioid system as involved in 
the pathophysiology of TS and also suggest a new potential 
therapeutic target.
After whole exome sequencing of 100 trios (TS patients and 
their parents), point mutations in ASH1 Like Histone Lysine 
Methyltransferase (ASH1L) causing defects in its enzymatic 
activity were identified as a susceptibility gene for TS9, 
previously associated with mental retardation and autism. A 
transgenic mouse line (Ash1l heterozygous mice) indeed 
displayed  tic-like motor and compulsive behaviors, and dopamin-
ergic hyperinnervation was observed in the dorsal striatum, 
demonstrating good construct validity for this model.
           Amendments from Version 1
We thank the reviewer for their appreciation of our work. As 
requested, we have expanded on the paper regarding TBI and 
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Two more genes, chromodomain helicase DNA binding 
protein 8 (CHD8) and Signal Peptide, CUB Domain And EGF 
Like Domain Containing 1 (SCUBE1), were identified by whole 
exome sequencing in a cohort of 222 OCD parent-child trios, 
and it was further shown that these genes overlap with genes 
previously implicated in TS10. Of note, Katayama et al. (2016) 
demonstrated that mice heterozygous for Chd8 mutations mani-
fest ASD-like behavioral characteristics including increased 
anxiety, repetitive behavior, and altered social behavior11.
Using the Swedish National Registry, it was shown that 
maternal polycystic ovary syndrome (PCOS), as a model for 
investigating the role of prenatal androgen exposure, is a risk 
for TS, ADHD and ASD12. These results support a potential 
causal influence of prenatal androgen exposure on the devel-
opment of male-predominant neuropsychiatric disorders in 
female offspring of women with PCOS.
Still in Sweden, Brander et al.13 investigated whether, at the 
population level, tic-related OCD has a stronger familial load 
than non-tic-related OCD. They found that the risk of OCD in 
relatives of individuals with tic-related OCD was consider-
ably greater than the risk of OCD in relatives of individuals with 
non-tic-related OCD, concluding that tic-related OCD is a 
particularly familial subtype of OCD. The results have important 
implications for ongoing gene-searching efforts.
Environmental risk factors. The EMTICS study was a large 
European multicenter trial investigating, among several subjects, 
the role of immunology in the etiology of tics, a long-discussed 
hypothesis in the context of Pediatric Acute-onset Neuropsy-
chiatric Syndrome (PANS) / Pediatric Autoimmune Neuropsy-
chiatric Disorders Associated with Streptococcal Infections 
(PANDAS). A first paper on neuronal surface proteins on 188 
patients with TS failed to confirm a link between pathogenic 
antibodies and causation of tics14. In line with these findings, 
Baumgaertel et al.15 failed to detect autoantibodies in the 
CSF of 20 adult patients with TS. However, 20% of these 
patients had positive oligoclonal bands, an intriguing 
finding with no clear-cut explanation to date. Also, in the 
neuroimmunological field, Gilbert provides a thoughtful review of 
the PANDAS/PANS controversy16.
Chen et al.17, using the National Health Insurance Research 
Database of Taiwan, analyzed 2261 TS patients and 20349 
non-TS controls for the risk of traumatic brain injury (TBI). During 
follow-up, there was a significantly increased risk for TBI 
in TS patients compared to controls. Classic comorbidities such 
as ADHD, OCD and depression increased the risk for TBI, 
whereas the regular use of antipsychotic medication decreased 
it. These findings have important therapeutic implications, 
as it underlines the need to offer proper and sustained anti-tic 
treatment in patients, even if these treatments may be sedative, 
as may be the case for antipsychotics.
Pathophysiology
Singer and Augustine have published two excellent and 
exhaustive reviews on the pathophysiology of tics/TS (including 
controversies) and the relevance for pharmacotherapy18,19.
Electrophysiology. Loo et al.20 performed a 128-channel 
electroencephalogram (EEG) study on children with TS during 
an exaggerated blink task and showed overall higher gamma 
band spectral power and differences in theta, alpha, and beta 
band power in inferior parietal cortex in TS children compared 
to controls.
Niccolai et al.21 studied motor-related beta oscillations in TS 
using magnetoencephalography and showed a biphasic increase-
decrease pattern of beta oscillations. The decrease of beta 
oscillations was observed close to tic execution, similarly to 
what was observed in voluntary actions. The initial increase 
in beta power positively correlated with premonitory urges. 
Similarly, Zaparolli et al.22 studied the neural activity over 
the sensorimotor cortex using EEG during a finger move-
ment task in TS and found decreased levels of beta modulation 
compared to controls in tic-free conditions. However, the abnor-
mal pattern normalized if the patients were actively suppressing 
tics during the task.
Zhu et al.23 recorded local field potentials in the globus 
pallidus internus (GPi) and sub-thalamic nucleus (STN) of patients 
with TS and found that beta and gamma oscillations in the GPi 
were restored after deep brain stimulation (DBS) of the GPi 
but not after DBS of the STN, suggesting that these oscillations 
may play a role in pathophysiology of persistent tics. Another 
study using microelectrode recordings of the STN during 
DBS surgery in a single TS patient was able to identify a 
single unit activity of the STN within the delta band, which was 
reliably associated to optimal DBS target site for tic control24.
Neuroimaging studies. Ramkiran et al.25 used graph theoretical 
measures applied to resting-state functional magnetic resonance 
imaging (fMRI) in adults with TS and studied functional prop-
erties of different portions of cortico-basal ganglia-cerebellar 
networks. They showed increased basal ganglia-cortical and 
thalamo-cortical connectivity but reduced cortico-cerebellar 
connectivity compared to controls. The authors also reported 
reductions in serial information transfer within the default 
mode and the salience functional networks. Altogether, the 
findings suggested disruption of interoceptive mechanisms 
and of brain maturation, as well as a shift towards excitatory 
neurotransmission in TS.
Sigurdson et al.26 focussed on cerebellar morphology and 
structural connectivity (structural co-variance) in TS and 
found reduced grey matter volumes in part of the cerebellum 
involved in motor and cognitive information processing com-
pared top controls. The cerebellum also had abnormal structural 
connectivity with sensori-motor networks and fontal and cin-
gulate cortices. These findings highlight the importance of the 
cerebellum in tic pathophysiology. The same approach of struc-
tural co-variance was used to study the structural underpinnings 
of premonitory urges with a specific focus on the right insula27. 
The severity of tics and premonitory urges correlated, respec-
tively, with posterior (representing the current physiological 
state) and anterior (associated with urges for action) sub-regions 
of the insula. In addition, these sub-regions of insular cortex 
were related to different structural networks, suggesting that 
separate networks support tics and premonitory urges in TS.
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In one of the largest to date studies on resting state functional 
connectivity in adults and children with TS, Neilson et al.28 
showed that patterns of functional connections alterations 
were age-dependent: while brain networks in TS children pre-
sented features of older age, adult TS brain networks appeared 
“younger” in comparison to age-matched controls. Overall, these 
findings underline the differences in TS neurodevelopmental 
trajectories.
Finally, O’Neil et al. wrote a comprehensive review about 
neuroimaging findings on the role of the cingulate cortex in 
TS, suggesting that at least six to eight different sub-regions 
of this cortical area might be implicated in different aspects 
of TS pathophysiology, and are especially involved with pre-
monitory urges29. Activity in the subgenual and pregenual 
anterior cingulate as well as in the middle cingulate cortex 
might represent volitional effort, physical discomfort and 
emotional distress of premonitory urges; the posterior middle 
cingulate cortex and dorsal posterior cingulate cortex might 
play a role in amplification (build-up) of urges.
A positron emission tomography study of 33 adults found 
that serotonin transporter (SERT) binding in caudate and 
midbrain was normal in people with tics only or OCD only, but 
was elevated in people with both tics and OCD30. This result, 
if replicated, may suggest a nosological distinction between 
TS with vs. without OCD, which would be surprising from a 
clinical viewpoint.
Clinical and neuropsychological studies. Recent studies 
indicate that the coordination of bimanual movements may 
involve a number of brain areas: primary sensorimotor cortex, 
supplementary motor area (SMA), premotor cortex, cingulate 
motor cortex, lateral premotor cortex, basal ganglia, inferior 
parietal cortex, and the cerebellum (many of which, inciden-
tally, have been reported to be altered with respect to structure 
and/or function in brain imaging studies of TS). However, it 
is accepted that interhemispheric transfer is mediated through 
excitatory and inhibitory transcallosal communications between 
cortical motor areas and that the corpus callosum therefore 
plays a major role in the coordination of bimanual move-
ments, particularly asymmetric bimanual movements. A recent 
study investigated externally paced (cued) and internally paced 
bimanual tapping in adults with and without TS. Impor-
tantly, this study combined behavioral measures of bimanual 
tapping with MRI-based diffusion tensor imaging and probabi-
listic tractography of inter-hemispheric callosal connections 
between the SMA and the left SMA–putamen fiber tract31. TS 
patients were significantly less accurate than healthy indi-
viduals when asked to maintain a previously copied rhythmic 
tapping speed at time intervals < 1 Hz32. Unimanual tapping is 
the condition requiring the greatest level of interhemispheric 
inhibition. TS patients also showed altered fractional anisotropy 
in interhemispheric (SMA–SMA) and left-sided SMA–putamen 
fiber tracts. These findings are consistent with compensatory 
processes linked to self-regulation of motor control that may 
occur through the plastic rearrangement of interhemispheric 
and cortical-subcortical WM pathways.
Maigaard and colleagues studied the ability of children with 
TS to suppress quick but inappropriate rewards33. Not 
surprisingly, children with ADHD did poorly on this task, 
but children with TS actually did better than healthy control 
children. All groups improved their accuracy when a reward 
was promised for accuracy. One hypothesis to explain these 
results may be that children with TS have better motor inhibi-
tion in certain tasks due to their experience withholding tics 
in response to premonitory urges due to social pressures. The 
reward effect may correspond to the known improvement in tic 
suppression in the presence of immediate rewards5,34.
Treatment
Psychological interventions. In a large study of manualized 
CBT in children with OCD, anxious and depressive symptoms 
improved substantially and were not linked to improvements 
in OCD severity35. This result is one more argument in favor 
of psychotherapy for obsessions and compulsions, which are 
common in people with tics. A consensus report argues strongly 
for early intervention in OCD36. Since early-onset OCD is asso-
ciated with tics37, a similar argument could be made for early 
intervention in tic disorders, especially since effective behav-
ioral treatments without side effects are available. Studies of 
whether early intervention changes the course of tic disorders 
are needed.
One of the most interesting possibilities in delivering behavior 
therapy for tics has come from the development of internet-
based platforms, making these approaches available for a large 
number of patients, even in remote areas. The BIP-TIC plat-
form, developed in Sweden, allows to use either habit reversal 
training (HRT), exposure response prevention (ERP) or a mixture 
of both online with a possible intervention of a therapist by 
phone or email. A first pilot study on 23 patients has shown 
encouraging results in a rater-blind parallel group trial (includ-
ing a 12 month follow up)38. A large (n= +200) UK-based study 
of ERP using this platform, called ORBIT, will commence 
shortly39.
Another way to increase the number of patients to be reached 
by CBT is group therapy. A Danish study, using a combined 
HRT/ERP approach has demonstrated that it is equally effective 
in a group as in an individual setting with 27 patients per 
treatment arm40. This represents a promising and interesting way 
forward in CBT for tics.
Medication. The American Academy of Neurology (AAN) 
practice guidelines for TS41,42 are one of the most important 
publications in our field for 2019. A detailed analysis goes 
way beyond the scope of this review but it might be worth 
noting that the only “high confidence in the evidence” rating 
was awarded to Comprehensive Behavioral Intervention for 
Tics (CBIT) and not pharmacological or surgical therapies for 
tics. This represents a true paradigm shift in the field. Similar 
conclusions were drawn in another review of evidence-based 
treatments for TS and CTD32.
In recent years, cannabis and cannabis-derived products are 
being considered for the treatment of tics – and a variety of 
Page 5 of 11
F1000Research 2020, 9:1314 Last updated: 13 JAN 2021
other movement disorders. Milosev et al.43 present results from a 
retrospective data analysis and an online survey on the use 
of cannabis-based medicine for tics and comorbidities in TS. 
Patients (n= 98 and 40) expressed a preference for medical 
cannabis (rich in THC) over dronabinol and nabiximols. 
However, results from large randomized trials are still awaited 
and will help guide therapeutic decisions. These will also 
depend, obviously, on the availability of different cannabis-based 
medications across countries.
Neurosurgery. Blocking tics by behavior therapy or botulinum 
toxin has been hypothesized to interrupt the sensory-motor 
feedforward loop likely operating in TS, i.e. premonitory 
sensations triggering tics which then re-inforce premonitory 
sensations. Kimura et al.44 report on four patients who had 
undergone thalamic DBS for severe TS. In two, DBS could 
be completely withdrawn four and seven years after surgery, 
respectively, without re-increase in tics. This is intriguing 
and confirms unpublished reports from other centers, including 
our own (Paris). The authors raise the question of whether 
some of the tics observed pre-op were functional tics. Alter-
natively, perhaps some patients with severe tics may need 
treatment only for several years during development, when tics 
may have been most severe without treatment. On the topic of 
functional tics, which are occasionally seen by movement 
disorder specialists, Ganos et al.45 have published a landmark 
review which should be compulsory reading in the field.
In a 48 month follow-up of a multicentre trial comprising 
16 severe TS patients treated with DBS of the anterior 
pallidum, it was found that 75% of subjects were treatment 
responders, that YGTSS (-40%) and global functioning scores 
decreased significantly, and that self-injurious behaviors 
ceased in all affected (n=7) patients46. Also, no persistent 
psychiatric or neurological side effects were noted. However, 
DBS did not lead to overall decrease in medication. Predictors 
of long-term outcome for DBS in TS are still needed 
and larger, perhaps international studies will be able to fill 
that gap. One step towards that was signalled by a report of 
initial results from an international TS-DBS registry relating 
DBS active contact location to outcomes47.
Other treatments. Regarding unusual treatment methods 
for tics, Murakami et al.48 describe the use of oral splints in 
22 patients with TS. Tic decrease was noted in the vast majority 
of cases and occurred almost instantaneously. The authors 
suggest a placebo effect and/or a sensory trick as mechanism 
of action. The major question here remains how and if such an 
intervention can work long term and without impairing daily 
functioning, especially speech.
A pilot study evaluated the efficacy of a resource activation 
program as an alternative intervention for children and ado-
lescents (n=24) with tic disorders49. Their preliminary results 
suggest that after 16 treatment sessions, tics were significantly 
diminished using the YGTSS and other tic-related measures. 
Larger cohorts and longer follow-up will hopefully establish 
whether this approach might become an alternative or adjunct 
to established CBT approaches for treating tics such as HRT 
and ERP.
Conclusions
They are the same as last year (and likely for a while to come) 
but worth reiterating, and consist of several simple but 
important questions: Why do tics tend to start at ages 5–10? 
Why are they more common in boys? Why do they tend to 
improve during sleep? Why do tics usually improve in early 
adulthood? How accurately can we predict outcome for 
an individual patient? Which patients need which treatments? 
Is secondary prevention possible? Hopefully future studies 
will address these and other important issues.
Data availability
No data are associated with this article.
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